儿童严重喘的管理:当前的见解和未来的方向
Maria De Filippo1,2, Riccardo Castagnoli2,3, Ilaria Brambilla2,3
1Department of Maternal Infantile and Urological Sciences, AOU Policlinico Umberto I, Rome, Italy.
Expert review of clinical immunology
|April 13, 2025
概括
严重的儿科喘需要个性化治疗. 针对2型炎症的生物疗法是有前途的,但在获得和响应变异性方面的挑战需要解决,以便在儿童中获得更好的结果.
科学领域:
- 儿科呼吸系统医学 儿科呼吸系统医学
- 免疫学 免疫学 免疫学
- 精准医学是一门精准的医学.
背景情况:
- 严重的儿科喘会影响一小部分儿童,导致严重的发病率和医疗费用.
- 疾病的复杂性源于不同的表型,内型和炎症途径,使诊断和管理复杂化.
- 精准医学的进步,包括2型炎症的生物疗法,为治疗提供了新的途径.
研究的目的:
- 审查当前关于严重儿科喘的知识,涵盖病理生理学,表型和治疗方法.
- 探索生物标志物和内型在儿童喘个性化治疗中的作用.
- 检查重症儿科喘管理的挑战,包括非2型炎症和生物治疗的获取.
主要方法:
- 综合的文献搜索侧重于生物疗法,诊断创新和护理模式.
- 综合当前关于严重儿科喘病理生理学和临床表型的知识.
- 对儿科喘的挑战和新兴护理模式的批判性检查.
主要成果:
- 针对2型炎症的生物疗法在治疗严重儿科喘方面取得了重大进展.
- 生物标志物和内型对于指导个性化治疗策略至关重要.
- 挑战仍然存在,包括定义治疗反应,验证生物标志物和克服生物获取成本障碍.
结论:
- 在高风险儿童中早期启动生物疗法和多学科护理对于改善结果至关重要.
- 未来的研究应该专注于预测算法,新疗法和公平获取.
- 这种模式可能会转向疾病预防,重新定义儿科喘护理.
相关概念视频
Asthma-IV: Diagnostic and Management
2.5K
The diagnosis and management of asthma are comprehensive, encompassing clinical assessments, lung function tests, and pharmacological interventions. Here's an overview:
Clinical Assessment for Asthma:
This is the first step in diagnosing and managing asthma. It includes:
Clinical Assessment for Asthma:
This is the first step in diagnosing and managing asthma. It includes:
2.5K
Asthma: Pathogenesis and Management
298
Asthma is a chronic pulmonary condition involving inflammation of the airways, hyper-reactivity, and reversible obstruction of the airways. This condition can significantly impact a person's quality of life, making breathing difficult and leading to distressing symptoms.
Asthma is classified as allergic and non-allergic. Allergens such as dust mites, pollen, and pet dander trigger allergic asthma, while factors like cold air, intense emotions, or exercise can induce non-allergic asthma.
Asthma is classified as allergic and non-allergic. Allergens such as dust mites, pollen, and pet dander trigger allergic asthma, while factors like cold air, intense emotions, or exercise can induce non-allergic asthma.
298
Asthma-IV: Nursing Management
2.9K
The nursing management of asthma is a comprehensive approach that relies heavily on the expertise and dedication of healthcare professionals. It involves thorough assessment, accurate diagnosis, strategic planning, effective implementation, and diligent evaluation. By meticulously following this step-by-step process, healthcare professionals play a crucial role in providing the best possible care and treatment for patients with asthma, enhancing their overall health and well-being.
First, in...
First, in...
2.9K
Antiasthma Drugs: Mast Cell Stabilizers and Anti-IgE Drugs
204
Asthma is a chronic respiratory condition for which new therapeutic avenues, including anti-inflammatory drugs like mast cell stabilizers and anti-IgE treatments, continue to be developed.
Mast cell stabilizers, such as cromolyn (also known as sodium cromoglycate) and nedocromil (Tilade), are effective drugs in asthma management. These stabilizers hinder histamine release by skillfully obstructing the activation of mast cells and other cellular entities. Notably, they navigate this task without...
Mast cell stabilizers, such as cromolyn (also known as sodium cromoglycate) and nedocromil (Tilade), are effective drugs in asthma management. These stabilizers hinder histamine release by skillfully obstructing the activation of mast cells and other cellular entities. Notably, they navigate this task without...
204
Asthma-III: Symptoms and Complications
2.4K
Asthma, a common chronic respiratory condition, is classified considering the frequency and severity of symptoms alongside lung function impairment. Understanding this classification is essential for appropriate treatment and management. Here's a detailed look at the classification of asthma and its clinical features and complications:
Classification of Asthma
Classification of Asthma
2.4K
Drugs Used in Lower Respiratory Disorders: Overview
329
Lower respiratory tract disorders present challenges that often require skilled and nuanced approaches for effective management. Common ailments, such as asthma and chronic obstructive pulmonary disease (COPD), have prompted the development of intricate treatment strategies involving bronchodilators and anti-inflammatory drugs, each tailored to ease breathing and revitalize the lungs.
Bronchodilators, the first step of respiration enhancement, come in various forms, each with its own mechanism...
Bronchodilators, the first step of respiration enhancement, come in various forms, each with its own mechanism...
329


